Risk factors associated with methicillin resistance among staphylococcus aureus infections in veterans

Infection Control and Hospital Epidemiology

Volumn 31, Issue 1, 2010, Pages 36-41

  McCarthy, Natalie L ^a   Sullivan, Patrick S ^a   Gaynes, Robert ^b,c   Rimland, David ^b,c,d  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INFECTION RISK; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN RESISTANCE; STAPHYLOCOCCUS INFECTION; VETERAN;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BOSTON; CARRIER STATE; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NOSE; OROPHARYNX; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VETERANS; YOUNG ADULT;

EID: 72449132013     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/649017     Document Type: Article

References (31)

1. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
2. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-suceptible Staphylococcus aureus bacteremia: ameta-analysis. Clin Infect Dis 2003; 36:53-59. (Pubitemid 36099097)
3. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and at tributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162:2229-2235.
4. Shurland S, Zhan M, Bradham DD, Roghmnn M. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin- susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28:273-279.
5. Wang J, Chen S, Wang J, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008; 46:799-806.
6. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29:1171-1177.
7. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198:336-343.
8. Sadoyama G, Gontijo Filho PP. Risk factors for methicillin resistant and sensitive Staphylococcus aureus infection in a Brazilian university hospital. Braz J Infect Dis 2000; 4:135-143.
9. Munckhof WJ, Nimmo GR, Carney J, et al. Methicillin-susceptible, nonmultiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis 2008; 27: 355-364.
10. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332.
11. Klevens RM, Morrison MA, Fridkin SK, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006; 12:1991-1993.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
13. Kleinbaum DG, Klein M. Logistic Regression: A Self-Learning Text. 2nd ed. New York, NY: Springer; 2002.
14. Jorgensen JH. Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the United States. Eur J Clin Microbiol 1986; 5:693-696.
15. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991; 91(Suppl 3B):221S-227S.
16. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1995; 98:599-600.
17. Haley CC, Mittal D, LaViolette A, Jannapureddy S, Parvez N, Haley RW. Methicillin-resistant Staphylococcus aureus infection or colonization present at hospital admission: multivariable risk factor screening to increase efficiency of surveillance culturing. J Clin Microbiol 2007; 45:3031-3038.
18. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-674.
19. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36: 281-285.
20. Beam JW, Buckley B. Community-acquired methicillin-resistant Staphylococcus aureus: prevalence and risk factors. J Athl Train 2006; 41:337-340.
21. Bradley S, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med 1991; 115:417-422.
22. Bakowski E, Wey SB, Medeiros EAS. Risk factors for bacteremia and predictors of mortality of patients with bloodstream infection with methicillin-resistant Staphylococcus aureus. Am J Infect Dis 2008; 4:174-178.
23. Wang F, Chen Y, Chen T, Liu C. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control 2008; 36:118-122.
24. Chi C, Wong W, Fung C, Yu K, Liu C. Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect 2004; 37:16-23.
25. Lowy FD, Aiello AE, Bha M, et al. Staphylococcus aureus colonization and infection in New York state prisons. J Infect Dis 2007; 196:911-918.
26. Vanden F, Naimi T, Enright MC, et al. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978-984.
27. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44:471-482.
28. Crum NF, Lee RU, Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006; 119:943-951.
29. Diederen BMW, Kluytmans JAJW. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 2006; 52:157-168.
30. Rollason J, Bastin L, Hilton AC, et al. Epidemiology of community-acquired methicillin-resistant Staphylococcus aureus obtained from the UK West Midlands region. J Hosp Infect 2008; 70:314-320.
31. Muto C, Jerigan J, Ostrowsky B, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386. (Pubitemid 36612323)